NCT01789281 Everolimus Roll-over Protocol for Patients Who Have Completed a Previous Novartis-sponsored Everolimus Study. Status COMPLETED Phase PHASE4
NCT01787552 A Phase Ib/II Dose-finding Study to Assess the Safety and Efficacy of LDE225 + INC424 in Patients With MF Status COMPLETED Phase PHASE1/PHASE2
NCT01785602 Efficacy and Safety Study of QAW039 in the Treatment of Patients With Moderate to Severe Atopic Dermatitis. Status COMPLETED Phase PHASE2
NCT01785472 Efficacy and Safety of LCZ696 in Comparison to Olmesartan in Asian Patients With Essential Hypertension Status COMPLETED Phase PHASE3
NCT01784068 Nilotinib Treatment-free Remission Study in CML (Chronic Myeloid Leukemia) Patients Status COMPLETED Phase PHASE2
NCT01783444 A Phase II Study of Everolimus in Combination With Exemestane Versus Everolimus Alone Versus Capecitabine in Advance Breast Cancer. Status COMPLETED Phase PHASE2
NCT01782326 QVA vs. Salmeterol/Fluticasone, 52-week Exacerbation Study, FLAME (EFfect of Indacaterol Glycopyronium Vs Fluticasone Salmeterol on COPD Exacerbations) Status COMPLETED Phase PHASE3
NCT01780935 Efficacy and Safety of Two Treatment Regimens of 0.5 mg Ranibizumab Intravitreal Injections Guided by Functional and/or Anatomical Criteria, in Patients With Neovascular Age-related Macular Degeneration Status COMPLETED Phase PHASE3
NCT01778062 Indacaterol EfectIveness In COPD Patients With Tuberculosis History Status COMPLETED Phase PHASE3
NCT01775124 Efficacy and Safety of Ranibizumab 0.5 mg Administered as Two Alternative Dosing Regimens in Chinese Patients With nAMD (Age Related Macular Degeneration) Status COMPLETED Phase PHASE4
NCT01772797 Phase Ib Study of LDK378 and AUY922 in ALK-rearranged Non-small Cell Lung Cancer Status COMPLETED Phase PHASE1
NCT01770379 Secukinumab Efficacy and Safety Study in Patients With Rheumatoid Arthritis and Inadequate Response to Anti-TNFα Agents. Status TERMINATED Phase PHASE3
NCT01769768 Phase I Study to Evaluate the Effect of LDE225 on the Pharmacokinetics of Bupropion and Warfarin in Patients Status COMPLETED Phase PHASE1
NCT01769547 A Phase II Study of Single-agent DOVitinib in Advanced Malignant PlEural Mesothelioma Which Has Progressed Following Prior Platinum-Antifolate Chemotherapy Status TERMINATED Phase PHASE2
NCT01766778 Early add-on Vildagliptin in Patients With Type 2 Diabetes Inadequately Controlled by Metformin Status COMPLETED Phase PHASE4
NCT01762761 Eltrombopag Phase III Study In Chinese Chronic ITP Patients Status COMPLETED Phase PHASE3